While more commonly linked to autoimmune disorders, some forms of interstitial lung disease (ILD) may be exacerbated by chronic mould spore exposure. Repeated inflammation can lead to fibrotic changes in lung tissue. Treatment focuses on reducing exposures, supportive measures (like oxygen therapy), and, occasionally, immunosuppressive drugs, depending on the specific ILD.
